Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Shire LLC et al v. Teva Pharmaceuticals USA Inc. et al
Case Number:
1:10-cv-00329
Court:
Nature of Suit:
Judge:
Firms
Companies
- Allergan PLC
- Anchen Pharmaceuticals Inc.
- Supernus Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
May 31, 2013
Shire, Teva Call Truce In Fight Over Generic ADHD Drug
A Shire PLC unit said Friday that it had reached a settlement with Teva Pharmaceuticals USA Inc. resolving allegations that Teva infringed two patents for the attention deficit hyperactivity disorder drug Intuniv.
-
April 25, 2013
Shire Ends Patent War With Actavis, Watson Over ADHD Drug
A unit of pharmaceutical giant Shire PLC said Thursday that it had reached a settlement with Actavis Inc. and Watson Pharmaceuticals Inc., resolving all pending patent litigation over the companies' attempts to market generic versions of the attention deficit hyperactivity disorder drug Intuniv.